Related Experiment Videos
Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene
1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
Cancer Research
|April 1, 1994
Summary
Drug-resistant cancer is a major challenge. Researchers identified a new gene, multidrug resistance-associated protein (mrp), that contributes to multidrug resistance, offering hope for new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Drug-resistant cancer cells pose a significant challenge to effective chemotherapy.
- The multidrug-resistant phenotype often limits the success of combination chemotherapy strategies.
- While mdr1 is known to cause multidrug resistance, other mechanisms are suspected due to mdr1-independent resistant cell lines.
Purpose of the Study:
- To identify novel genes responsible for conferring a multidrug-resistant phenotype.
- To explore alternative mechanisms of drug resistance beyond mdr1.
- To validate a new method for discovering resistance genes.
Main Methods:
- Utilized a novel approach involving expression complementary DNA (cDNA) library transfer.
- Transferred cDNA libraries into cells to screen for drug resistance.
- Investigated the role of specific genes in conferring multidrug resistance.
Main Results:
- Successfully identified the multidrug resistance-associated protein (mrp) gene as capable of conferring a multidrug-resistant phenotype.
- Demonstrated that mrp, a member of the ABC cassette superfamily, contributes to drug efflux.
- Confirmed the existence of mdr1-independent mechanisms of multidrug resistance.
Conclusions:
- The novel expression cDNA library transfer approach is effective for identifying new drug resistance genes.
- The mrp gene is a significant contributor to the multidrug-resistant phenotype.
- This methodology holds promise for discovering additional novel resistance genes in cancer therapy.